Margin resik: Boundless Bio, Inc. (BOLD)

Logo grafis Boundless Bio Inc (BOLD)

Unique patents in oncotherapy create a powerful defensive moat, as evidenced by the net margin on this chart, where the value 0.00 determines this level. Boundless Bio, Inc. (BOLD) strengthens market confidence through its status as a pioneer in the fight against aggressive tumors. Meanwhile, strict FDA oversight and a preference for joint research over mergers limit the scaling pace of Boundless Bio, Inc. (BOLD).

BOLD: Tingkat bathi resik Boundless Bio Inc 29.03.2024 - 19.11.2026

Rincian metrik komprehensif lan analitis Boundless Bio, Inc (BOLD)

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Analisis dhasar perusahaan:Boundless Bio Inc., BOLD
Produk asil prodhuksi Boundless Bio Inc.

Net profit margin measures the efficiency of converting revenue into bottom-line profit after deducting all expenses. By analyzing the net profit margin, an investor assesses the business's ability to generate real cash flow. This ratio reveals the internal stability of the model and the level of operating leverage. For Boundless Bio, Inc. (BOLD), current negative values reflect a stage of intensive R&D expenditures. Future growth in this metric will signal the commercialization of therapies and the realization of a patent monopoly.

Pesaing Boundless Bio, Inc. (BOLD)

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX